Strong balance sheet key to PGX dealsCZO has disclosed that more than one bio-chemical giant has expressed interest in PGX. To strike any deal with a big trans-national, Ceapro has to demonstrate the financial wherewithal to deliver on technology scale-up. The latest money raise - despite its shortcomings - positions CZO to capitalize on this transformative, materials processing technology. The market has yet to truly price in PGX. That`s good news for the incredibly good news story that is Ceapro. Long and strong!